| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO & President | President & COO
1 company
Danny Prosky is Director at AHR. From May 2017 to July 2026, the filings on record show 43 open-market purchases and 0 sales. Danny Prosky's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $17.6M at current prices.
Net of sales, the AHR filings show accumulation of 218,983 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2018 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,289 | $9.21 | $11,871.69 | +3.1% | |
| Mar 22, 2018 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,288 | $9.21 | $11,862.48 | +3.2% | |
| Mar 7, 2018 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,307 | $9.21 | $12,037.47 | +3.3% | |
| Feb 22, 2018 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,309 | $9.21 | $12,055.89 | +3.5% | |
| Feb 7, 2018 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,309 | $9.21 | $12,055.89 | +3.6% | |
| Jan 22, 2018 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 7,017 | $9.21 | $64,626.57 | +23.8% | |
| Jan 8, 2018 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,075 | $9.21 | $9,900.75 | +3.8% | |
| Dec 22, 2017 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,318 | $9.21 | $12,138.78 | +4.9% | |
| Dec 7, 2017 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,318 | $9.21 | $12,138.78 | +5.1% | |
| Nov 22, 2017 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,318 | $9.21 | $12,138.78 | +5.4% |